Education Information
2011 - 2016
2011 - 2016Doctorate
Istanbul University, Onkoloji Enstitüsü, Temel Onkoloji Abd Kanser Biyokimyası Bilim Dalı, Turkey
2008 - 2011
2008 - 2011Postgraduate
Istanbul University, Temel Onkoloji Abd, Kanser Biyokimyası, Turkey
2004 - 2008
2004 - 2008Undergraduate
Ege University, Faculty Of Science, Biyokimya Bölümü, Turkey
Dissertations
2016
2016Doctorate
AKCİĞER KANSERLİ HASTALARDA HGF, cMET, EGF ve EGFR PROTEİNLERİ VE BU PROTEİNLERİN mRNA DÜZEYLERİNİN BELİRLENMESİ
Istanbul University, Temel Onkoloji Abd, Kanser Biyokimyası
2011
2011Postgraduate
Hepatosellüler Karsinomlu Hastalarda VEGF, IL-6 ve GLİPİKAN-3'ün Klinik Önemi
Istanbul University, Temel Onkoloji Abd, Kanser Biyokimyası Bölümü
Foreign Languages
B2 Upper Intermediate
B2 Upper IntermediateEnglish
Certificates, Courses and Trainings
2022
20228th International BAU Drug Design Congress
Vocational Training
Bahçeşehir Üniversitesi
2022
2022Computer-Aided Drug Design (CADD) Symposium and Workshop – Linking Design, Biology, Chemistry and Medicine
Vocational Training
Biruni Üniversitesi
2018
2018ARAŞTIRMADA VE TIBBI UYGULAMADA KULLANILAN MOLEKÜLER LABORATUVAR TEKNIKLERI: UYGULAMALI EĞITIM KURSU
Vocational Training
Türk Biyokimya Derneği
2018
2018Yeni Nesil Dizi Analizi ve Onkolojide Kullanım Alanları Kursu
Health&Medicine
Temel Onkoloji Derneği
2016
2016Tübitak 1000 Projeleri ARGE Strateji Çalıştayı
R&D Management
İstanbul Üniversitesi
2016
20167.İstanbul Üniversitesi Onkoloji Enstitüsü Çalıştayı
Health&Medicine
İstanbul Üniversitesi
2014
2014İş Sağlığı ve Güvenliği
Occupational Health and Safety
İstanbul Üniversitesi
2014
20141.Moleküler Üroloji Toplantısı
Health&Medicine
Üroonkoloji Derneği
2011
2011Moleküler ve Translasyonel Onkoloji Kursu
Health&Medicine
Tıbbi Onkoloji Derneği
Research Areas
Medicine
Health Sciences
Fundamental Medical Sciences
Biochemistry
Academic Titles / Tasks
2009 - Continues
2009 - ContinuesMedical Doctor
Istanbul University, Onkoloji Enstitüsü, Temel Onkoloji Ana Bilim Dalı
Managerial Experience
2023 - Continues
2023 - ContinuesMuayene ve Kabul Komisyonu Üye
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
2022 - Continues
2022 - ContinuesKimyasal Dökülme, Saçılma Müdahale Birim Sorumlusu
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
2019 - 2022
2019 - 2022Birim Eğitim Sorumlusu Tıbbi Biyokimya Laboratuvarı
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
2021 - 2021
2021 - 2021İhale Komisyonu Uzman Üyesi
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
2019 - 2019
2019 - 2019Muayene ve Kabul Komisyon Yedek Üye
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
2017 - 2018
2017 - 2018Muayene ve Kabul Komisyonu Yedek Üye
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
2015 - 2015
2015 - 2015Muayene ve Kabul Komisyonu Yedek Üye
Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri
Courses
Published journal articles indexed by SCI, SSCI, and AHCI
2021
2021Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?
Yitgin Y., Erdem S., Serilmez M., Duranyıldız D., Verep S., Gasimov K., et al.
International Journal of Clinical Practice , vol.75, no.8, 2021 (SCI-Expanded)
2020
2020Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
Karabulut M., Afsar C. U., Serilmez M., Karabulut S.
Journal of cancer research and therapeutics , vol.16, 2020 (SCI-Expanded)
2019
2019Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
Erturk K., Karaman S., Dagoglu N., Serilmez M., Duranyildiz D., Tas F.
WIENER KLINISCHE WOCHENSCHRIFT , no.17-18, pp.419-426, 2019 (SCI-Expanded)
2019
2019The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer
Ucuncu M., Serilmez M., Sari M., Bademler S., Karabulut S.
BIOMOLECULES , vol.9, no.9, 2019 (SCI-Expanded)
2019
2019Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M., Afsar C. U., Serimez M., Karabulut S.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24, no.4, pp.1601-1609, 2019 (SCI-Expanded)
2019
2019Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer
Bademler S., Ucuncu M. Z., Yasasever C., Serilmez M., Ertin H., Karanlik H.
BIOMOLECULES , vol.9, no.3, 2019 (SCI-Expanded)
2019
2019Serum IL-17 levels can be diagnostic for gastric cancer
Karabulut M., Usul Afşar Ç., Serilmez M., Karabulut S.
Journal Of Buon , vol.24, no.4, pp.1-9, 2019 (SCI-Expanded)
2019
2019Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy
Serilmez M., Ozgur E., Karaman Ş., Gezer U., Duranyildiz D.
CANCER BIOMARKERS , no.2, pp.177-184, 2019 (SCI-Expanded)
2019
2019SERUM AKT2 LEVELS AS A MARKER FOR LUNG CANCER
Karaman Ş., Erturk K., Serilmez M., Duranyilidiz D., Oral E. N., Dagoglu N.
ACTA MEDICA MEDITERRANEA , no.6, pp.3269-3272, 2019 (SCI-Expanded)
2018
2018Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
Afsar C. U., Karabulut M., Karabulut S., Ozal S. T., Cikot M., Serilmez M., et al.
BIOMOLECULES , vol.8, no.4, 2018 (SCI-Expanded)
2018
2018Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer
BADEMLER S., Sari M., Üçüncü M. Z., SERİLMEZ M., Karabulut S.
Acta Medica Mediterranea , vol.34, no.6, pp.2055-2060, 2018 (SCI-Expanded)
2017
2017Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients
Erturk K., Tas F., Serılmez M., Bilgin E., Yasasever V.
Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.1383-1387, 2017 (SCI-Expanded)
2017
2017Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma
Afsar C. U., Karabulut M., Karabulut S., Alis H., Gonenc M., Dagoglu N., et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY , no.4, pp.196-200, 2017 (SCI-Expanded)
2016
2016Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma
Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.
Arab Journal of Gastroenterology , vol.17, no.4, pp.164-167, 2016 (SCI-Expanded)
2016
2016Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients
Guveli M. E., Duranyildiz D., Karadeniz A., Bilgin E., Serilmez M., Soydinc H. O., et al.
TUMOR BIOLOGY , vol.37, no.7, pp.8979-8983, 2016 (SCI-Expanded)
2016
2016Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
KARABULUT M., GUNALDI M., ALIS H., AFSAR C., KARABULUT S., Serilmez M., et al.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , vol.18, pp.160-71, 2016 (SCI-Expanded)
2016
2016Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.
BIOMEDICINE & PHARMACOTHERAPY , vol.77, pp.86-91, 2016 (SCI-Expanded)
2016
2016Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer
Tas F., Karabulut S., Serilmez M., KARABULUT M., Duranyildiz D.
CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.77, no.1, pp.127-131, 2016 (SCI-Expanded)
2016
2016Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer
Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.
TUMOR BIOLOGY , vol.37, no.1, pp.405-412, 2016 (SCI-Expanded)
2016
2016CLINICAL SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR (HGF) AND ITS RECEPTOR CMET LEVELS IN COLORECTAL CANCER PATIENTS
KARABULUT M., ALIS H., GUNALDI M., AFSAR C. U., Karabulut S., KONES O., et al.
ACTA MEDICA MEDITERRANEA , vol.32, no.1, pp.179-187, 2016 (SCI-Expanded)
2015
2015Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma
Sen F., Yildiz I., Odabas H., Tambas M., Kilic L., Karadeniz A., et al.
TUMOR BIOLOGY , vol.36, pp.1039-1044, 2015 (SCI-Expanded)
2015
2015D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.
Kilic L., Yildiz I., Sen F. K., ERDEM M. G., Serilmez M., Keskin S., et al.
Cancer biomarkers : section A of Disease markers , vol.15, no.4, pp.405-11, 2015 (SCI-Expanded)
2014
2014The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer
Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.
TUMOR BIOLOGY , vol.35, no.9, pp.8849-8860, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum tenascin-C levels in breast cancer
Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.
TUMOR BIOLOGY , vol.35, no.7, pp.6619-6625, 2014 (SCI-Expanded)
2014
2014Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients
Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.
TUMOR BIOLOGY , vol.35, no.4, pp.3327-3331, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer
Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.
TUMOR BIOLOGY , vol.35, no.4, pp.3125-3132, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer
Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.
TUMOR BIOLOGY , vol.35, no.4, pp.3095-3102, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer
Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.
TUMOR BIOLOGY , vol.35, no.4, pp.3611-3616, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma
Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.
TUMOR BIOLOGY , vol.35, no.3, pp.2729-2739, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma
Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.
TUMOR BIOLOGY , vol.35, no.3, pp.2327-2333, 2014 (SCI-Expanded)
2014
2014Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer
Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.
CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.73, no.3, pp.631-637, 2014 (SCI-Expanded)
2013
2013Clinical significance of serum M30 and M65 levels in melanoma
Tas F., Karabulut S., Serilmez M., Yildiz I., Sen F., Ciftci R., et al.
MELANOMA RESEARCH , vol.23, no.5, pp.390-395, 2013 (SCI-Expanded)
2013
2013Clinical and prognostic significance of coagulation assays in gastric cancer.
Tas F., Ciftci R., Kilic L., Serilmez M., Karabulut S., Duranyildiz D.
Journal of gastrointestinal cancer , vol.44, pp.285-92, 2013 (SCI-Expanded)
2013
2013A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer
Yildiz I., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2, pp.437-444, 2013 (SCI-Expanded)
2013
2013Clinical and prognostic significance of coagulation assays in lung cancer
Tas F., Kilic L., Serilmez M., Keskin S., Sen F., Duranyildiz D.
RESPIRATORY MEDICINE , vol.107, no.3, pp.451-457, 2013 (SCI-Expanded)
2013
2013For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?
Bilgin E., Dizdar Y., Serilmez M., Soydinc H. O., Yasasever C., Duranyildiz D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.4, pp.2541-2544, 2013 (SCI-Expanded)
2011
2011Immobilization and stabilization of alpha-galactosidase on Sepabeads EC-EA and EC-HA
Bayraktar H., Serilmez M., Karkas T., Celem E. B., ÖNAL S.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.49, no.4, pp.855-860, 2011 (SCI-Expanded)
2010
2010Hematological parameters in lung cancer Akciǧer kanserinde hematolojik parametreler
SERİLMEZ M., Oǧuz H. O., ÇAMLICA H., TOPUZ E., DURANYILDIZ D.
Turk Onkoloji Dergisi , vol.25, no.3, pp.87-92, 2010 (SCI-Expanded)
Articles Published in Other Journals
2021
2021Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer
Ak N., Serilmez M., Ucuncu M. Z., Bademler S., Vatansever S.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.36, no.2, pp.165-170, 2021 (ESCI)
2020
2020Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma.
Çavuş B., Akyuz F., İliaz R., Akyuz U., Duranyıldız D., Serilmez M., et al.
Experimental oncology , vol.42, no.3, pp.208-214, 2020 (Scopus)
2018
2018Significance of serum neural precursor cell-expressed developmentally downregulated protein 9 in melanoma
Erturk K., Tas F., Serılmez M., Bilgin E., Duranyıldız D.
MOLECULAR AND CLINICAL ONCOLOGY , vol.8, no.1, pp.204-208, 2018 (ESCI)
2018
2018Serum Glypican-3, Vascular Endothelial Growth Factor, and lnterleukin-6 Levels in Hepatocellular Carcinoma
Serilmez M., Akyuz F., Ormeci Ciftcibasi A., Karabulut S., Kaymakoglu S., Yasasever V., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.33, no.1, pp.18-27, 2018 (ESCI)
2016
2016Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma
Karabulut S., Afsar C. U., Karabulut M., Alis H., Bozkurt M. A., Aydogan F., et al.
BBA CLINICAL , vol.6, pp.138-142, 2016 (ESCI)
2016
2016Is serum tenascin-C level potential biomarker in pancreatic adenocarcinoma?
Karabulut S., KARABULUT M., ALIS H., Tambas M., KAPAN S., KONES O., et al.
MEDICAL JOURNAL OF BAKIRKOY , vol.12, no.2, pp.76-82, 2016 (ESCI)
2010
2010Akciğer Kanserinde Hematolojik Parametreler
SERİLMEZ M., OĞUZ SOYDİNÇ H., CAMLICA H., TOPUZ E., DURANYILDIZ D.
TÜRK ONKOLOJİ DERGİSİ , vol.25, no.3, pp.87-92, 2010 (Scopus)
2010
2010Hematological parameters in lung cancer
SERİLMEZ M., OĞUZ SOYDİNÇ H., Camlica H., Topuz E., DURANYILDIZ H. D.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.25, no.3, pp.87-92, 2010 (ESCI)
Refereed Congress / Symposium Publications in Proceedings
2023
2023Prognostic Importance of BRAF and PTEN Proteins in Patients with Malignant Melanoma
Bilgin Doğru E., Tilgen Yasasever C., Serilmez M., Taş F., Duranyıldız H. D., Oğuz Soydinç H.
IX. INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE “MOLECULAR MEDICINE IN LIFE SCIENCES”, İstanbul, Turkey, 18 - 20 December 2023, pp.1
2018
2018Tensin-2 Molekülünün Meme Kanserli Hastalardaki Önemi
TİLGEN YASASEVER C., BİLGİN E., serilmez m., OĞUZ SOYDİNÇ H., BADEMLER S., KARANLIK H.
29. Ulusal Biyokimya Kongresi Bodrum-Muğla, Muğla, Turkey, 26 - 30 October 2018
2017
2017Importance of AXL Molecule in Lung Cancers
Kizir A., Bilgin Doğru E., Tilgen Yasasever C., Serilmez M.
15. İstanbul Üniversitesi Onkoloji Enstitüsü Günleri Sempozyumu ve 8. İstanbul Üniversitesi Onkoloji Enstitüsü Çalıştayı, İstanbul, Turkey, 1 - 02 December 2017, pp.1
2017
2017Meme Kanserli Hastalarda TIMP-1, HA ve SPARC Düzeyleri
Tilgen Yasasever C., Bilgin Doğru E., Serilmez M., Öztürk N., Yasasever F. V.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.162
2017
2017Over Kanserinde HMGB1 ve IRE1'in Önemi
BİLGİN DOĞRU E., TİLGEN YASASEVER C., SERİLMEZ M., SAİP P. M., YASASEVER F. V.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.159
2016
2016Clinical significance of serum cmet and hgf protein and mRNA levels in lung cancer.
SERİLMEZ M., ÖZGÜR E., KARAMAN Ş., OĞUZ SOYDİNÇ H., DURANYILDIZ D., YASASEVER V.
41st Congress of the Federation of European Biochemical Societies (FEBS), İzmir, Turkey, 3 - 08 September 2016, pp.1
2016
2016Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi
ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.
3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Turkey, 11 - 15 May 2016, pp.1
2016
2016Over Kanserli Hastalarda Prolaktin ve Interlökin-10’un Rolü”
SERİLMEZ M., OĞUZ SOYDİNÇ H., KURU O., DURANYILDIZ D., YASASEVER V.
6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1
2016
2016Meme Kanserli Hastalarda NGAL ve MMP-9'un Kemoterapi İle Değişimi
OĞUZ SOYDİNÇ H., SERİLMEZ M., ŞEN F., DURANYILDIZ D., YASASEVER V.
6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1
2015
2015Hepatosellüler karsinomda galektin-3 ve fibronektin molekülleri yeni bir tümör belirteci olabilir mi?
SERİLMEZ M., AKYÜZ M., TAŞTEKİN D., OĞUZ SOYDİNÇ H., DURANYILDIZ D.
21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1
2012
2012Meme kanserli hastalarda plazma D-Dimer düzeylerinin tümör yükü ve metastazı ile ilişkisi
KILIC L., ŞEN F., YILDIZ İ., KESKİN S., EKENEL M., SERİLMEZ M., et al.
4. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2012, pp.250
2011
2011Angiogenesis markers in nasopharynx and larynx cancers
Serilmez M., Bilgin E., Yasasever V., Duranyildiz D.
36th FEBS Congress of the Biochemistry for Tomorrows Medicine, Torino, Italy, 25 - 30 June 2011, vol.278, pp.233
2011
2011What kind of a role may play IFN-gamma and emmprin in head and neck cancers?
Bilgin E., Serilmez M., Duranyildiz D., Yasasever V.
36th FEBS Congress of the Biochemistry for Tomorrows Medicine, Torino, Italy, 25 - 30 June 2011, vol.278, pp.197
2011
2011Baş-Boyun kanserlerinde VEGF-C’nin yeri var mı?
Serilmez M., BİLGİN E., KARADENİZ A. N., Yildiz I., YASASEVER F. V.
19. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1
2011
2011Kolon ve rektum karsinomlu hastalarda EGFR IL-6 ve IL-10 düzeyleri
SERİLMEZ M., OĞUZ SOYDİNÇ H., KILIÇ L., UZUNOĞLU S., TAŞ F., DURANYILDIZ D.
19.Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1
2011
2011Mide karsinomlarında sitokin ve epidermal büyüme faktörü (EGFR) düzeyleri
SERİLMEZ M., OĞUZ SOYDİNÇ H., CICIN I., UZUNOĞLU S., DURANYILDIZ D.
19.Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1
2010
2010Renal function tests in childhood cancer
OĞUZ SOYDİNÇ H., SERİLMEZ M., YASASEVER V.
The 5th APOCP Conference, İstanbul, Turkey, 3 - 07 April 2010, pp.1
2010
2010The levels of plasma fibrinogen in cancer patients
SERİLMEZ M., OĞUZ SOYDİNÇ H., DURANYILDIZ D.
The 5th APOCP Conference, İstanbul, Turkey, 3 - 07 April 2010, pp.1
2009
2009Platin-bazlı kemoterapi alan hastalarda üre- kreatinin değerleri
OĞUZ SOYDİNÇ H., SERİLMEZ M., TAŞ F., YASASEVER V.
21. Ulusal Biokimya Kongresi, İstanbul, Turkey, 28 - 31 October 2009, pp.1
2009
2009Akciğer kanserli hastalarda kemoterapi ve radyoterapinin hematolojik parametreler üzerine etkisi
SERİLMEZ M., OĞUZ SOYDİNÇ H., TAŞ F., DURANYILDIZ D.
21. Ulusal Biokimya Kongresi, İstanbul, Turkey, 28 - 31 October 2009, pp.1
Supported Projects
2017 - 2018
2017 - 2018Baş-Boyun Kanserlerinde DCLK1 Molekülü
Project Supported by Higher Education Institutions
KARADENİZ A. N. (Executive), SERİLMEZ M., KARAMAN Ş., TİLGEN YASASEVER C., BİLGİN DOĞRU E.
2016 - 2017
2016 - 2017Küçük Hücre Dışı Akciğer Kanserlerinde PTEN ve BRAF Moleküllerinin Önemi
Project Supported by Higher Education Institutions
SERİLMEZ M. (Executive), OĞUZ SOYDİNÇ H., YASASEVER F. V., DURANYILDIZ H. D., KARAMAN Ş.
2014 - 2016
2014 - 2016Akciğer Kanserli Hastalarda HGF,cMET,EGF ve EGFR Proteinleri ve Bu Proteinlerin mRNA Düzeylerinin Belirlenmesi
Project Supported by Higher Education Institutions
DURANYILDIZ H. D. (Executive), SERİLMEZ M.
Memberships / Tasks in Scientific Organizations
2023 - Continues
2023 - ContinuesEuropean Society For Medical Oncology
Member
2017 - Continues
2017 - ContinuesBasic Oncology Society
Member
2011 - Continues
2011 - ContinuesTurkish Biochemical Society
Member
Awards
March 2020
March 2020Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy
Akciğer Sağlığı Ve Yoğun Bakım Derneği Uask 2020
Congress and Symposium Activities
11 May 2022 - 12 May 2022
11 May 2022 - 12 May 20222.Computer-Aided Drug Design Symposium and Workshop
Attendee
İstanbul-Turkey
16 September 2021 - 18 September 2021
16 September 2021 - 18 September 20213. Uluslararası Kanser ve İyon Kanalları Kongresi
Audience
İstanbul-Turkey
15 February 2021 - 17 February 2021
15 February 2021 - 17 February 2021Critical Role of Clinical Laboratories in the Covid-19 Pandemic IFCC VIRTUAL CONFERENCE
Attendee
Milan-Italy
15 January 2021 - 16 January 2021
15 January 2021 - 16 January 2021Covid-19 Pandemisinde Araştırma-Yayın ve Eğitim Süreçlerine Bakış Kongresi
Attendee
İzmir-Turkey
19 December 2020 - 19 December 2020
19 December 2020 - 19 December 202018. İSTANBUL ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ GÜNLERİ "Dünyada Klinik Uygulamaları Etkileyen Çalışmalar
Attendee
İstanbul-Turkey
07 July 2018 - 12 July 2018
07 July 2018 - 12 July 201843rd FEBS Congress
Attendee
Praha-Czech Republic
03 April 2017 - 07 April 2017
03 April 2017 - 07 April 20175th Apocp Conference
Attendee
İstanbul-Turkey
15 March 2017 - 19 March 2017
15 March 2017 - 19 March 2017Ulusal Akciğer Sağlığı Kongresi
Attendee
Antalya-Turkey
27 January 2017 - 30 January 2017
27 January 2017 - 30 January 2017ECCO 2017 Congress
Attendee
Amsterdam-Netherlands
03 September 2016 - 08 September 2016
03 September 2016 - 08 September 201641th FEBS Congress
Attendee
Aydın-Turkey
23 March 2016 - 27 March 2016
23 March 2016 - 27 March 20166.Tıbbi Onkoloji Kongresi
Attendee
Antalya-Turkey
04 July 2015 - 09 July 2015
04 July 2015 - 09 July 201540th FEBS Congress
Attendee
Berlin-Germany
22 April 2015 - 26 April 2015
22 April 2015 - 26 April 201521. Ulusal Kanser Kongresi
Attendee
Antalya-Turkey
21 March 2015 - 25 March 2015
21 March 2015 - 25 March 20154,Tıbbi Onkoloji Kongresi
Attendee
Antalya-Turkey
19 December 2014 - 21 December 2014
19 December 2014 - 21 December 201412.İstanbul Üniversitesi Onkoloji Enstitüsü Günleri Sempozyum
Attendee
İstanbul-Turkey
22 October 2014 - 22 October 2014
22 October 2014 - 22 October 2014Karaköy Otofaji Sempozyumu
Attendee
İstanbul-Turkey
22 June 2014 - 26 June 2014
22 June 2014 - 26 June 2014IFCC WORLDLAB
Attendee
İstanbul-Turkey
19 March 2014 - 23 March 2014
19 March 2014 - 23 March 20145.Türk Tıbbi Onkoloji Kongres
Attendee
Antalya-Turkey
04 September 2012 - 09 September 2012
04 September 2012 - 09 September 201222nd IUBMB & 37th FEBS Congress
Attendee
Sevilla-Spain
17 November 2011 - 18 November 2011
17 November 2011 - 18 November 20113. DETAE Günleri
Attendee
İstanbul-Turkey
25 June 2011 - 30 June 2011
25 June 2011 - 30 June 201136th FEBS Congress
Attendee
Turin-Italy
20 April 2011 - 24 April 2011
20 April 2011 - 24 April 201119. Ulusal Kanser Kongresi
Attendee
Antalya-Turkey
16 December 2010 - 19 December 2010
16 December 2010 - 19 December 20108. istanbul Üniversitesi Onkoloji Enstitüsü Günleri
Attendee
Antalya-Turkey
28 October 2009 - 31 October 2009
28 October 2009 - 31 October 200921.Ulusal Biyokimya Kongresi
Attendee
İstanbul-Turkey
Scholarships
2021 - 2022
2021 - 2022